Abstract | INTRODUCTION: Due to being hard to heal, chronic ulcers account for high morbidity. OBJECTIVE: This study compares the safety and efficacy of 2 formulations of cadexomer iodine and standard care for the treatment of chronic ulcers. MATERIALS AND METHODS: This prospective, randomized, open-label clinical trial was conducted at 8 cities across 15 institutions in India from March 2016 to March 2017. After screening a total of 145 patients with chronic, recalcitrant ulcers, 124 were randomized to 1 of 3 treatments: 0.9% cadexomer iodine ointment plus standard care (n = 41), 0.9% cadexomer iodine powder plus standard care (n = 43), and standard care alone (n = 40). All patients completed the maximum treatment period of 12 weeks, with the exception of 8 who discontinued during the study period. At the end of the treatment period, endpoints were assessed. RESULTS: The percentage of reduction in ulcer size from baseline to the primary endpoint of 12 weeks was significantly higher with both formulations of cadexomer iodine ointment (94.3% ± 10.6%) and powder (90.4% ± 14.9%) as compared with standard care alone (67.8% ± 21.8%). The percentage of patients with complete wound healing at the end of the 12 weeks was significantly higher in patients treated with both formulations of cadexomer iodine ointment (65.8%) and powder (58.1%) as compared with standard care alone (20.0%). CONCLUSIONS: These results demonstrate that cadexomer iodine, in comparison with standard care alone, increases the percentage of reduction in ulcer size and promotes complete wound healing in chronic ulcers.
|
Authors | Radhakrishnan Raju, Sunil Naik Kethavath, Satyanarayana Murthy Sangavarapu, Praveen Kanjarla |
Journal | Wounds : a compendium of clinical research and practice
(Wounds)
Vol. 31
Issue 3
Pg. 85-90
(Mar 2019)
ISSN: 1943-2704 [Electronic] United States |
PMID | 30720444
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Infective Agents, Local
- Iodophors
- Ointments
- Powders
- cadexomer iodine
|
Topics |
- Adult
- Anti-Infective Agents, Local
(administration & dosage, pharmacology, therapeutic use)
- Chronic Disease
(drug therapy)
- Debridement
- Female
- Humans
- India
- Iodophors
(administration & dosage, pharmacology, therapeutic use)
- Male
- Middle Aged
- Ointments
- Powders
- Prospective Studies
- Treatment Outcome
- Ulcer
(drug therapy, pathology)
- Wound Healing
(drug effects, physiology)
- Young Adult
|